From Name:
From Email:
To Name:
To Email:

Optional Message:


Samsung Bioepis wins FDA approval for rheumatoid arthritis drug that competes with Johnson & Johnson

from CNBC

South Korea's Samsung Bioepis has won a U.S. FDA nod for a biosimilar of Johnson & Johnson's Remicade, marking a first for the company in the U.S. and setting up a path to competition with the world's largest drug company and a similar product made by Pfizer. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063